Broadcom Hits $419 on AI Chip Hype — But Can Custom Silicon Carry a $2 Trillion Valuation?

Shares surged +4.3% to $419.34 after Zacks named Broadcom its "Bull of the Day" for the second time in ten days, spotlighting the chipmaker's explosive push into custom AI processors. The call lands as Wall Street grapples with a fundamental question: is Broadcom becoming the indispensable alternative to Nvidia — or is the stock running on expectations that are nearly impossible to meet?

- 106% AI Revenue Growth Is Real, but the Easy Gains May Be Over. AI revenue reached $8.4 billion in fiscal Q1 2026, a 106% year-over-year increase.

Total revenue hit $19.31 billion, up 29%, with adjusted EPS of $2.05 beating estimates. That AI line now represents 43% of total sales. Management guided Q2 AI revenue to $10.7 billion — a 140% year-over-year jump. But here's the catch: gross margin slipped to 77% from 79.1% a year earlier, suggesting that fast-growing custom chip products carry lower margins than legacy semiconductor lines. Growth is spectacular; profitability per dollar is quietly eroding.

- Big Tech's Spending Spree Is Broadcom's Lifeline — and Its Risk. The five largest U.S. tech companies are projected to spend over $630 billion on AI infrastructure in 2026. Broadcom's custom chips — tailor-made processors for Google, Meta, and now Anthropic — are capturing a growing slice. The company recently landed an $11 billion AI chip order from Anthropic for the second half of 2026 and added an unnamed new customer. But if those hyperscalers trim budgets or bring more chip design fully in-house, Broadcom's pipeline dries up fast.

- The $100 Billion Target Requires Near-Perfect Execution. CEO Hock Tan says Broadcom has "clear line of sight" to $100 billion in annual AI chip revenue by late 2027, backed by a $73 billion backlog.

J.P. Morgan projects total revenue could reach $55–60 billion in fiscal 2026, rising past $100 billion in fiscal 2027. Achieving that depends entirely on TSMC successfully executing its most aggressive factory expansion plan ever.

- The Valuation Looks Reasonable — If the Growth Holds. Shares trade at 25.9× forward earnings, with the price-to-growth ratio at 0.5× — the lowest level in years and well below the five-year median of 1.2×.

After nine months of consolidation driven by skepticism about AI spending sustainability, valuations have reset while fundamentals kept strengthening. That makes today's rally less speculative and more catch-up — unless the AI spending cycle turns.